EnzyRazer is dedicated to the independent development and manufacturing of tissue-specific single-cell dissociation enzymes, with a clear mission: to convert complex tissues into high-viability, high-integrity single-cell suspensions in a precise and controlled manner.
Rather than relying on one-size-fits-all formulations, EnzyRazer offers tailored multi-enzyme solutions optimized for different tissue types, including tumors, heart, liver, lung, spleen, brain, and other structurally challenging or fibrotic tissues. This design philosophy ensures minimal cellular damage, high cell yield, and excellent preservation of surface antigens and transcriptomic integrity.
EnzyRazer products are broadly compatible with downstream applications such as single-cell sequencing (scRNA-seq, scATAC-seq, snRNA-seq), flow cytometry and cell sorting, organoid research, primary cell culture, and cell and gene therapy workflows. By combining robust performance with strong cost efficiency, EnzyRazer significantly reduces experimental variability and breaks long-standing dependence on imported enzyme brands.
From fundamental research to translational and clinical applications, EnzyRazer is building a scalable product and service ecosystem spanning research-grade, industrial-grade, and future GMP-grade solutions—turning single-cell preparation from a fragile art into a reproducible, standardized, and trustworthy foundation for modern life science research.